Rey A, Klein B, Rucheton M, Caraux J, Zagury D, Thierry C, Serrou B
Cell Immunol. 1984 Jun;86(1):155-64. doi: 10.1016/0008-8749(84)90368-x.
Peripheral blood lymphocytes (PBL) of solid-tumor-bearing cancer patients produced a lower interleukin 2 (IL-2) activity after lectin stimulation than did those from normal subjects. Moreover natural killer (NK) cell activity and autologous rosette forming (ARF) cell rate are found significantly correlated with IL-2 production in these patients. No direct relation is observed between ARF cell ratio and NK cell activity in a given patient. A central role for IL-2 in cancer patient immune dysfunctions is suggested. Two lines of pathogenetic mechanisms are documented. First, PBL exhibited cellular function defects, namely, autologous receptor expression, IL-2 production, and NK activity. Second, these dysfunctions involved, at least partly, plasma factors. The possibility of specific deficiency, (e.g., thymic factors) is not documented. Conversely it is demonstrated that patient plasma contain immunosuppressive factor(s) that block(s) IL-2 production and ARF cell expression. Involvement of ARF cell receptor in T-cell activation is discussed.
实体瘤癌症患者的外周血淋巴细胞(PBL)在凝集素刺激后产生的白细胞介素2(IL-2)活性低于正常受试者。此外,在这些患者中发现自然杀伤(NK)细胞活性和自体花环形成(ARF)细胞率与IL-2产生显著相关。在给定患者中,未观察到ARF细胞比例与NK细胞活性之间的直接关系。提示IL-2在癌症患者免疫功能障碍中起核心作用。记录了两条发病机制。第一,PBL表现出细胞功能缺陷,即自体受体表达、IL-2产生和NK活性。第二,这些功能障碍至少部分涉及血浆因子。未记录到特异性缺乏(如胸腺因子)的可能性。相反,已证明患者血浆含有抑制IL-2产生和ARF细胞表达的免疫抑制因子。讨论了ARF细胞受体在T细胞激活中的作用。